INTERACTION OF PEPTIDE FRAGMENT-828-848 OF THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I WITH LIPID BILAYERS

被引:68
|
作者
GAWRISCH, K [1 ]
HAN, KH [1 ]
YANG, JS [1 ]
BERGELSON, LD [1 ]
FERRETTI, JA [1 ]
机构
[1] MM SHEMYAKIN BIOORGAN CHEM INST,117988 MOSCOW,RUSSIA
关键词
D O I
10.1021/bi00063a024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of the peptide fragment 828-848, called P828, from the carboxy-terminal region of the envelope glycoprotein gp41 of HIV-1 with model membranes composed of phosphatidylcholine (PC) and phosphatidylglycerol (PG) was investigated using microelectrophoretic mobility of liposomes, fluorescence polarization of labeled lipids, NMR, and differential scanning calorimetry. The peptide binds to negatively charged lipid surfaces. No interaction between P828 and neutral PC surfaces is observed. The interaction between the peptide and the lipid is exclusively electrostatic with the six positively charged arginines of P828 acting as binding sites for PG. Circular dichroism measurements of P828 indicate that the peptide undergoes a transition from a random coil to an ordered conformation upon binding to negatively charged PG bilayers or SDS micelles, but not in the presence of neutral PC bilayers. The ordered structure has an apparent helical content of 60%. In DOPG/DOPC mixtures containing 20 mol % DOPG, the peptide causes the formation of lipid domains enriched in DOPG, as assessed by measurement of fluorescence energy transfer between labeled PG and PC. The formation of these domains requires energy and therefore reduces the strength of peptide binding to the lipid matrix. Our data support and quantitate the results from antibody binding studies [Haffar, O. K., Dowbenko, D. J., & Berman, P. W. (1988) J. Cell Biol. 107, 1677-1687] that the carboxy-terminal segment of the envelope glycoprotein gp41 interacts with microsomal membranes.
引用
收藏
页码:3112 / 3118
页数:7
相关论文
共 50 条
  • [21] ROLE OF THE MATRIX PROTEIN IN THE VIRION ASSOCIATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN
    DORFMAN, T
    MAMMANO, F
    HASELTINE, WA
    GOTTLINGER, HG
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1689 - 1696
  • [22] EXPRESSION AND CHARACTERIZATION OF A FUNCTIONAL HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN IN INSECT CELLS
    WELLS, DE
    COMPANS, RW
    VIROLOGY, 1990, 176 (02) : 575 - 586
  • [23] EFFECT OF A GLUCOSIDASE INHIBITOR ON THE BIOACTIVITY AND IMMUNOREACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN
    FENOUILLET, E
    GLUCKMAN, JC
    JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1919 - 1926
  • [24] THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STIMULATES RELEASE OF NEUROTOXINS FROM MONOCYTES
    GIULIAN, D
    WENDT, E
    VACA, K
    NOONAN, CA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 2769 - 2773
  • [25] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN IS MODIFIED BY O-LINKED OLIGOSACCHARIDES
    BERNSTEIN, HB
    TUCKER, SP
    HUNTER, E
    SCHUTZBACH, JS
    COMPANS, RW
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 463 - 468
  • [26] CAMPTOTHECIN INHIBITS TAT-MEDIATED TRANSACTIVATION OF TYPE-I HUMAN-IMMUNODEFICIENCY-VIRUS
    LI, CJ
    WANG, CL
    PARDEE, AB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (10) : 7051 - 7054
  • [27] SIMULTANEOUS INFECTIONS WITH HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I AND THE HUMAN-IMMUNODEFICIENCY-VIRUS
    KANNER, SB
    PARKS, ES
    SCOTT, GB
    PARKS, WP
    JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (04): : 617 - 625
  • [28] Immunogenicity of full length and truncated forms of the human immunodeficiency virus type I envelope glycoprotein
    McKeating, JA
    Shotton, C
    Jeffs, S
    Palmer, C
    Hammond, A
    Lewis, J
    Oliver, K
    May, J
    Balfe, P
    IMMUNOLOGY LETTERS, 1996, 51 (1-2) : 101 - 105
  • [29] PROTECTION OF MACAQUES WITH A SIMIAN IMMUNODEFICIENCY VIRUS ENVELOPE PEPTIDE VACCINE BASED ON CONSERVED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEQUENCES
    SHAFFERMAN, A
    JAHRLING, PB
    BENVENISTE, RE
    LEWIS, MG
    PHIPPS, TJ
    EDENMCCUTCHAN, F
    SADOFF, J
    EDDY, GA
    BURKE, DS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) : 7126 - 7130
  • [30] MODULATION OF IMMUNE-RESPONSES BY HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE PEPTIDE AND ETHANOL
    KUMAR, AN
    NAIR, MPN
    SCHWARTZ, SA
    CLINICAL RESEARCH, 1990, 38 (03): : A905 - A905